Gary Charles Robb

Chief Business Officer · Corcept Therapeutics

Gary Charles Robb (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $1.2M of CORT (10,000 sh × $116.26, as filed), executed Aug 17. Data as of Nov 7 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Aug 17

Filed Aug 18

Median ADV $130.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

CORT

Corcept Therapeutics Incorporated CORT · 0 buys · 6 sells 6 filings

Recent filings

CORTSALE Corcept Therapeutics Incorporated View filing → $1.2M
10,000 sh × $116.26
Exec Aug 17
Filed Aug 18 · 4:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $166K
2,326 sh × $71.27
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $225K
3,185 sh × $70.77
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $173K
2,279 sh × $75.85
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $556K
11,000 sh × $50.50
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $147K
2,609 sh × $56.20
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET